Doxycycline hyclate 100 MG tab 400S
Ended Awarded Last action
- Contract number
- SPE2DR26FSCC2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,766
Award facts
- Contract value 100% obligated
- $29,766.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,766.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of 400 tablets of Doxycycline Hyclate 100 mg. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 22, 2025, and was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) designated SPE2DR, which was recently awarded on November 13, 2025, under the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative.
The PPV-G GEN V program represents a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors supplying pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group's IDC carries a $499,999,999 ceiling value with a completion date of December 31, 2036, structured as a 30-month base period with three 30-month option periods. The contractor maintains no identified subcontractor relationships and has demonstrated substantial federal contracting performance through numerous delivery orders across diverse pharmaceutical categories, positioning it as a critical supplier within the military healthcare system's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FSCC2?
SPE2DR26FSCC2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26FSCC2 worth?
The government has obligated $29,766 on SPE2DR26FSCC2.
Is contract SPE2DR26FSCC2 an order under another contract?
Yes. SPE2DR26FSCC2 is a delivery order under SPE2DR25D9316, an indefinite delivery contract.
Was contract SPE2DR26FSCC2 competed?
The extent of competition for SPE2DR26FSCC2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award